News and Announcements
FarmaTrust Partners with Gaco Pharmaceuticals to Modernise & Secure it’s Supply Chain
- Published May 11, 2018 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
KEY TAKEAWAYS:
- FarmaTrust, a UK-based blockchain venture and international drug tracking system, has announced it’s second partnership in a short span of time with Gaco pharmaceuticals in Bangladesh after its association with Mongolian government.
- The company aims at safe, encrypted, transparent and unquestionable supply chain with elimination of counterfeit drugs.
Farma Trust is a premiere company for blockchain technology innovation which has a holistic approach to do away with fake and imitation drugs and at the same time creating efficiencies for the manufacturers. It intends to provide data analytics, machine learning and automated regulatory repotting which will automatically increase production efficiency and therefore ensure growth of the company.
Omer Farooque, the managing director of Gaco Pharmaceuticals proudly announced about its
association with the company, expecting modernisation and security of their supply chain. He confirmed about availability of an easy access tool, a freely downloadable mobile app to consumers so that they can in turn control the authencity of the medical products they yearn to purchase. Partnership with Farma Trust will provide them cost-efficient and comprehensive information modules. This would help Gaco to retain its credibility, quality of medicines and recognition.
About FarmaTrust
FarmaTrust provides cost effective data services to pharmaceutical companies to meet their compliance requirements, governments, regulators, NGOs and law enforcement. It also gives confidence to consumers (through the free FarmaTrust app) that medicines they purchase are genuine.
Company Updates
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be Attracting Big Pharma’s Attention
Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
Backed By Leading Investment Groups and Family Offices
